Sleep apnea treatment changed by weight loss drug Zepbound at Long Island clinics

August 1, 2025

•

1 min read

•

Newsday

The approval marked another step in the increasingly popular, and pricey, use of GLP-1 medications.

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved Zepbound, one of the new weight loss medications, as the... [7982 chars]

Read Original Article

Source: Newsday

Visit Source

Share this article

Twitter Facebook

Back to health news